News

Lobsters hold the secret of a long, cancer-free life in their genes

More than a mere delicacy, the humble lobster could teach us a lot about healthy aging
Mihaela Bozukova
By Mihaela Bozukova
Sept. 11, 2021

The American lobster — easily recognizable by its two hefty claws — can reach the impressive age of 100 years. The remarkable longevity is accompanied by very few signs of aging; it continuously grows and reproduces throughout its life and does not suffer from age-related diseases such as cancer. This exceptional resilience has garnered interest from researchers that are curious to decipher the reasons behind the lobster’s longevity and good health.

Lobster-445x334.jpg
Jeremy Zero on Unsplash

Could the genome of the American lobster provide clues about their healthy aging? Researchers at the Gloucester Marine Genomics Institute have recently published the first draft of the American lobster genome, which revealed surprising, first insights into the animal’s unique resilience mechanisms. Their work was published in the journal Science Advances.

The researchers found genes encoding for a novel class of proteins that combine both neuronal and immune-related functions. By coupling the neural and immune system, the lobster could fight off pathogens more efficiently.

The researchers also surveyed the lobster genome for genes involved in safeguarding the genome. These safeguards prevent genomic alterations and mutations, which is crucial for longevity and warding off cancer. The researchers found that the American lobster has an extended repertoire of genes encoding for proteins that silence certain regions of the genome. These regions need to be silenced to prevent potentially disease-causing mutations such as chromosomal rearrangements. By ensuring that these regions remain silenced, the American lobster safeguards its genome throughout its long life.

With the newly deciphered lobster genome as a starting point, future research will provide further insight into the healthy aging strategies of the American lobster. More than a mere delicacy, the humble lobster could teach us a lot about healthy aging.

This story originally appeared on Massive Science, an editorial partner site that publishes science stories by scientists. Subscribe to their newsletter to get even more science sent straight to you.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Mihaela Bozukova
Mihaela Bozukova

Mihaela Bozukova is a computational biologist and PhD candidate at the Max Planck Institute for Biology of Ageing. She is passionate about science communication and data visualization.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance
Webinar

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance

March 28, 2025

Alejandro Vila, an ASBMB Breakthroughs speaker, discussed his work on metallo-β-lactamase enzymes and their dependence on zinc.

Host vs. pathogen and the molecular arms race
ASBMB Annual Meeting

Host vs. pathogen and the molecular arms race

March 28, 2025

Learn about the ASBMB 2025 symposium on host–pathogen interactions, to be held Sunday, April 13 at 1:50 p.m.

Richard Silverman to speak at ASBMB 2025
ASBMB Annual Meeting

Richard Silverman to speak at ASBMB 2025

March 27, 2025

Richard Silverman and Melissa Moore are the featured speakers at the ASBMB annual meeting to be held April 12-15 in Chicago.

From the Journals: JBC
Journal News

From the Journals: JBC

March 25, 2025

How cells recover from stress. Cancer cells need cysteine to proliferate. Method to make small membrane proteins. Read about papers on these topics recently published in the Journal of Biological Chemistry.

ASBMB names 2025 JBC/Tabor Award winners
Award

ASBMB names 2025 JBC/Tabor Award winners

March 24, 2025

The six awardees are first authors of outstanding papers published in 2024 in the Journal of Biological Chemistry.

Pan-kinase inhibitor for head and neck cancer enters clinical trials
Journal News

Pan-kinase inhibitor for head and neck cancer enters clinical trials

March 18, 2025

A drug targeting the scaffolding function of multiple related kinases halts tumor progression.